Tom ntej: tert-Butyl 1 2 3-oxathiazolidine-3-carboxylate 2 2-dioxide (CAS # 459817-82-4)
Taw qhia
2,2-Dioxo-[1,2,3]oxathiazolidine-3-carboxylic acid tert-butyl ester yog ib qho compound.
Khoom: Tert-butyl ester 2,2-dioxo-[1,2,3] oxathiazolidine-3-carboxylic acid yog cov xim tsis muaj kob crystalline nrog cov txheeb ze molecular hnyav ntawm 203.25. Nws muaj zoo solubility nyob rau hauv cov organic solvents xws li ethanol, dimethyl sulfoxide, thiab acetone.
Siv: 2,2-Dioxo-[1,2,3]tert-butyl oxathiazolidine-3-carboxylic acid feem ntau yog siv los ua ib qho nruab nrab hauv cov organic synthesis.
Txoj kev npaj: Kev npaj ntawm 2,2-dioxo-[1,2,3] oxathiazolidine-3-carboxylic acid tert-butyl ester tuaj yeem tau los ntawm cov tshuaj tiv thaiv cyclization ntawm cov tshuaj tiv thaiv raw khoom 2-thiothiazolidinamine thiab carbon dioxide catalyzed los ntawm alkali . Rau cov txheej txheem synthesis tshwj xeeb, thov xa mus rau cov ntaub ntawv organic synthesis lossis patents.
Cov ntaub ntawv kev nyab xeeb: Rau toxicity thiab kev nyab xeeb cov ntaub ntawv thiab kev ceev faj rau tert-butyl ester 2,2-dioxo-[1,2,3]oxazolidine-3-carboxylate, nco ntsoov xa mus rau nws Daim Ntawv Qhia Kev Nyab Xeeb (SDS) lossis cuam tshuam txog kev nyab xeeb tshuaj. phau ntawv. Feem ntau, yuav tsum tau saib xyuas kom ua raws li cov txheej txheem ua haujlwm nyab xeeb ntawm chav kuaj thaum siv thiab khaws cov tshuaj, thiab siv cov kev tiv thaiv tus kheej tsim nyog, xws li hnav hnab looj tes tiv thaiv thiab tsom iav kev nyab xeeb.
